NASTAD

organization

Last mentioned: Mar 17, 2026

Timeline

  1. New Limits Reported

    States begin implementing restrictive eligibility and waitlists for drug assistance programs.

  2. Fiscal Pressure Mounts

    Rising costs of long-acting therapies and expiration of pandemic funding strain state budgets.

  3. Waitlist Peak

    National ADAP waitlists reached a record high of over 9,000 individuals following the Great Recession.

  4. Ryan White CARE Act

    Federal legislation established to provide a safety net for HIV/AIDS care and treatment.

Stories mentioning NASTAD 1

pharma Bearish

State Budget Cuts Force New Restrictions on HIV Drug Assistance Programs

Several states have begun implementing restrictive eligibility requirements and waitlists for AIDS Drug Assistance Programs (ADAPs), citing budgetary shortfalls and rising medication costs. This shift threatens to reverse years of progress in HIV viral suppression and places significant financial pressure on low-income patients and safety-net providers.

2 sources

About NASTAD coverage

This page surfaces every story mentioning NASTAD across our biotech coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.

Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running biotech beat. Cross-entity comparisons live on our compare view.

What you seeWhat it tells you
Story countNumber of distinct stories where NASTAD was a primary or referenced actor.
Recency clusteringWhether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc).
Sentiment distributionAggregate sentiment of the stories mentioning this entity, weighted by impact score.
Cross-niche linksWhen the same entity surfaces in our sibling networks, we link to those views to enrich context.